Article
Factor-V HR2 haplotype and thromboembolic disease.
Acta cardiologica - 1 Dec 2015
Aleksova Aneta, Di Nucci Milena, Gobbo Marco, Bevilacqua Elena, Pradella Paola, Salam Kassem, Barbati Giulia, De Luca Antonio, Mascaretti Luca, Sinagra Gianfranco
Abstract excerpt
OBJECTIVES: The objective of this study is to evaluate the prevalence of HR2 polymorphism among patients with pulmonary embolism (PE) and healthy subjects. BACKGROUND: Polymorphism in the factor V gene named HR2 has been described as a possible risk factor for venous thromboembolism (VTE) development. Contradictive results on this association have been reported. METHODS: Eighty-five patients admitted for PE and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
